Cathy O'Leary
Alzheimer’s answers still elusive
A lot of hope – and hype – surround the immunotherapy drugs flagged to treat Alzheimer’s disease. The jury is out on their real-life benefit, while the push continues for earlier diagnosis.
About the Author
Cathy O'Leary
Subscribe to continue reading
Log in or create an account to access the full article.